703 related articles for article (PubMed ID: 32228100)
1. Neuronal mitochondria-targeted therapy for Alzheimer's disease by systemic delivery of resveratrol using dual-modified novel biomimetic nanosystems.
Han Y; Chu X; Cui L; Fu S; Gao C; Li Y; Sun B
Drug Deliv; 2020 Dec; 27(1):502-518. PubMed ID: 32228100
[TBL] [Abstract][Full Text] [Related]
2. Neuronal mitochondria-targeted delivery of curcumin by biomimetic engineered nanosystems in Alzheimer's disease mice.
Gao C; Wang Y; Sun J; Han Y; Gong W; Li Y; Feng Y; Wang H; Yang M; Li Z; Yang Y; Gao C
Acta Biomater; 2020 May; 108():285-299. PubMed ID: 32251785
[TBL] [Abstract][Full Text] [Related]
3. Neuron tau-targeting biomimetic nanoparticles for curcumin delivery to delay progression of Alzheimer's disease.
Gao C; Chu X; Gong W; Zheng J; Xie X; Wang Y; Yang M; Li Z; Gao C; Yang Y
J Nanobiotechnology; 2020 May; 18(1):71. PubMed ID: 32404183
[TBL] [Abstract][Full Text] [Related]
4. Macrophage membrane-coated nanocarriers Co-Modified by RVG29 and TPP improve brain neuronal mitochondria-targeting and therapeutic efficacy in Alzheimer's disease mice.
Han Y; Gao C; Wang H; Sun J; Liang M; Feng Y; Liu Q; Fu S; Cui L; Gao C; Li Y; Yang Y; Sun B
Bioact Mater; 2021 Feb; 6(2):529-542. PubMed ID: 32995678
[TBL] [Abstract][Full Text] [Related]
5. Brain targeted peptide-functionalized chitosan nanoparticles for resveratrol delivery: Impact on insulin resistance and gut microbiota in obesity-related Alzheimer's disease.
Yang L; Wang Y; Li Z; Wu X; Mei J; Zheng G
Carbohydr Polym; 2023 Jun; 310():120714. PubMed ID: 36925241
[TBL] [Abstract][Full Text] [Related]
6. Delineation of Neuroprotective Effects and Possible Benefits of AntioxidantsTherapy for the Treatment of Alzheimer's Diseases by Targeting Mitochondrial-Derived Reactive Oxygen Species: Bench to Bedside.
Walia V; Kaushik D; Mittal V; Kumar K; Verma R; Parashar J; Akter R; Rahman MH; Bhatia S; Al-Harrasi A; Karthika C; Bhattacharya T; Chopra H; Ashraf GM
Mol Neurobiol; 2022 Jan; 59(1):657-680. PubMed ID: 34751889
[TBL] [Abstract][Full Text] [Related]
7. Oral Administration of Resveratrol-Selenium-Peptide Nanocomposites Alleviates Alzheimer's Disease-like Pathogenesis by Inhibiting Aβ Aggregation and Regulating Gut Microbiota.
Li C; Wang N; Zheng G; Yang L
ACS Appl Mater Interfaces; 2021 Oct; 13(39):46406-46420. PubMed ID: 34569225
[TBL] [Abstract][Full Text] [Related]
8. Neuronal mitochondria-targeted micelles relieving oxidative stress for delayed progression of Alzheimer's disease.
Yang P; Sheng D; Guo Q; Wang P; Xu S; Qian K; Li Y; Cheng Y; Wang L; Lu W; Zhang Q
Biomaterials; 2020 Apr; 238():119844. PubMed ID: 32062148
[TBL] [Abstract][Full Text] [Related]
9. Dual-drug loaded nanoparticles of Epigallocatechin-3-gallate (EGCG)/Ascorbic acid enhance therapeutic efficacy of EGCG in a APPswe/PS1dE9 Alzheimer's disease mice model.
Cano A; Ettcheto M; Chang JH; Barroso E; Espina M; Kühne BA; Barenys M; Auladell C; Folch J; Souto EB; Camins A; Turowski P; García ML
J Control Release; 2019 May; 301():62-75. PubMed ID: 30876953
[TBL] [Abstract][Full Text] [Related]
10. RVG29-Functionalized Lipid Nanoparticles for Quercetin Brain Delivery and Alzheimer's Disease.
Pinheiro RGR; Granja A; Loureiro JA; Pereira MC; Pinheiro M; Neves AR; Reis S
Pharm Res; 2020 Jul; 37(7):139. PubMed ID: 32661727
[TBL] [Abstract][Full Text] [Related]
11. Resveratrol loaded solid lipid nanoparticles attenuate mitochondrial oxidative stress in vascular dementia by activating Nrf2/HO-1 pathway.
Yadav A; Sunkaria A; Singhal N; Sandhir R
Neurochem Int; 2018 Jan; 112():239-254. PubMed ID: 28782592
[TBL] [Abstract][Full Text] [Related]
12. A diselenide bond-containing ROS-responsive ruthenium nanoplatform delivers nerve growth factor for Alzheimer's disease management by repairing and promoting neuron regeneration.
Yuan X; Jia Z; Li J; Liu Y; Huang Y; Gong Y; Guo X; Chen X; Cen J; Liu J
J Mater Chem B; 2021 Sep; 9(37):7835-7847. PubMed ID: 34586144
[TBL] [Abstract][Full Text] [Related]
13. Sialic acid (SA)-modified selenium nanoparticles coated with a high blood-brain barrier permeability peptide-B6 peptide for potential use in Alzheimer's disease.
Yin T; Yang L; Liu Y; Zhou X; Sun J; Liu J
Acta Biomater; 2015 Oct; 25():172-83. PubMed ID: 26143603
[TBL] [Abstract][Full Text] [Related]
14. Cationic biopolymer functionalized nanoparticles encapsulating lutein to attenuate oxidative stress in effective treatment of Alzheimer's disease: A non-invasive approach.
Dhas N; Mehta T
Int J Pharm; 2020 Aug; 586():119553. PubMed ID: 32561306
[TBL] [Abstract][Full Text] [Related]
15. Multifunctional Nanocarrier for Synergistic Treatment of Alzheimer's Disease by Inhibiting β-Amyloid Aggregation and Scavenging Reactive Oxygen Species.
Wang C; Song X; Li P; Sun S; Su J; Liu S; Wei W
ACS Appl Mater Interfaces; 2024 May; 16(21):27127-27138. PubMed ID: 38747495
[TBL] [Abstract][Full Text] [Related]
16. Mitochondria-Targeting Ceria Nanoparticles as Antioxidants for Alzheimer's Disease.
Kwon HJ; Cha MY; Kim D; Kim DK; Soh M; Shin K; Hyeon T; Mook-Jung I
ACS Nano; 2016 Feb; 10(2):2860-70. PubMed ID: 26844592
[TBL] [Abstract][Full Text] [Related]
17. Mitochondria-targeted antioxidant mitotempo protects mitochondrial function against amyloid beta toxicity in primary cultured mouse neurons.
Hu H; Li M
Biochem Biophys Res Commun; 2016 Sep; 478(1):174-180. PubMed ID: 27444386
[TBL] [Abstract][Full Text] [Related]
18. A Functionalized Octahedral Palladium Nanozyme as a Radical Scavenger for Ameliorating Alzheimer's Disease.
Jia Z; Yuan X; Wei JA; Guo X; Gong Y; Li J; Zhou H; Zhang L; Liu J
ACS Appl Mater Interfaces; 2021 Oct; 13(42):49602-49613. PubMed ID: 34641674
[TBL] [Abstract][Full Text] [Related]
19. ROS responsive resveratrol delivery from LDLR peptide conjugated PLA-coated mesoporous silica nanoparticles across the blood-brain barrier.
Shen Y; Cao B; Snyder NR; Woeppel KM; Eles JR; Cui XT
J Nanobiotechnology; 2018 Feb; 16(1):13. PubMed ID: 29433522
[TBL] [Abstract][Full Text] [Related]
20. Dual-Modified Novel Biomimetic Nanocarriers Improve Targeting and Therapeutic Efficacy in Glioma.
Fu S; Liang M; Wang Y; Cui L; Gao C; Chu X; Liu Q; Feng Y; Gong W; Yang M; Li Z; Yang C; Xie X; Yang Y; Gao C
ACS Appl Mater Interfaces; 2019 Jan; 11(2):1841-1854. PubMed ID: 30582685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
